Welcome to our dedicated page for STRATEGIC ACQUISITIONS /NV/ SEC filings (Ticker: STQN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STRATEGIC ACQUISITIONS /NV/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STRATEGIC ACQUISITIONS /NV/'s regulatory disclosures and financial reporting.
Strategic Acquisitions, Inc. reports a change in the location of its principal executive offices. Effective December 16, 2025, the address moved from 51 JFK Parkway, Suite 135, Short Hills, New Jersey 07078 to 2464 Darts Cove Way, (Mount Pleasant) Charleston, South Carolina 29466-0101.
The company lists its telephone number as (908) 266-0541 and confirms that its common stock trades under the symbol STQN.
Strategic Acquisitions, Inc. (STQN) filed its Q3 2025 report. The company reported no revenue, a small Q3 net income of $3,347 due mainly to a reversal of over‑accrued expenses, and a year‑to‑date net loss of $24,244. Cash was $1,936 and shareholders’ deficit was $(2,951) as of September 30, 2025.
The balance sheet strengthened modestly after a related‑party Loan Cancellation Agreement converted $103,321 of working capital loans into equity, lifting additional paid‑in capital to $457,056. The company had 6,675,000 shares outstanding as of October 31, 2025. There were no loans or digital asset collateral outstanding at quarter‑end; the 2024 loan and related note were settled in July 2024.
Management disclosed substantial doubt about the ability to continue as a going concern given limited cash and ongoing losses, and stated plans to seek financing. Internal controls were deemed not effective due to material weaknesses. Subsequent event: the Board authorized funding Q4 by selling common stock from treasury; no shares had been sold as of October 31, 2025.